Past Issue

Volume 9, Number 4, Jan-Mar 2016, Pages: 490-496

Metabolic Syndrome in Patients with Polycystic Ovary Syndrome in Iran


Ziba Zahiri, M.D, 1, *, Seyedeh Hajar Sharami, M.D, 1, Forozan Milani, M.D, 1, Fereshteh Mohammadi, M.D, 2, Ehsan Kazemnejad, PhD, 2, Hannan Ebrahimi, M.D, 1, Seyedeh Fatemeh Dalil Heirati, B.Sc, 1,
Reproductive Health Research Center, Obstetrics and Gynecology Department, Alzahra Hospital, Guilan University of Medical Sciences, Rasht, Iran
Guilan University of Medical Sciences, Rasht, Iran
* Corresponding Address: P.O. Box: 4144654839 Reproductive Health Research Center Obstetrics and Gynecology Department Alzahra Hospital Guilan University of Medical Sciences Rasht Iran Email:drzibazahiri@yahoo.com

Abstract

Background

The prevalence of metabolic syndrome (MetS) in polycystic ovary syndrome (PCOS) has been studied in different populations, but their results were so controversial regarding Iranian women. These controversial data indicated the need for more investigation of MetS characteristics in PCOS patients in our population. So this study aimed to evaluate the clinical and laboratory characteristics and metabolic features of patients with PCOS in Rasht.

Materials and Methods

This prospective cross sectional study was conducted on 215 PCOS women who lived in Rasht, north of Iran, from March 2010 to July 2012. The participants were then divided into two groups of women with MetS (n=62) and women without MetS (n=153). The diagnosis of PCOS and MetS were based on the Rotterdam 2003 criteria and the Adult Treatment Panel III (ATP III) criteria, respectively. Demographic characteristics, fertility characteristics, family history and laboratory findings were assessed.

Results

The prevalence of MetS in women with PCOS was 28.8%. In PCOS women of both groups, the waist circumference (WC) exceeded 88cm in 72.6%, hypertension [systolic blood pressure (SBP) and/or diastolic blood pressure (DBP) ≥130/85mm Hg] was prevalent in 9.3%, fasting blood sugar (FBS) level was ≥110 mg/dl in 6%, triglycerides (Tg) level were ≥150 mg/dl in 47%, and high-density lipoprotein (HDL) level was <50 mg/dl in 86%. The values of WC, SBP, DBP, body mass index (BMI), ovarian size, Tg, cholesterol, FBS, 2-hour blood sugar, aspartate aminotransferase (AST), and alanine aminotransferase (ALT) were significantly greater in PCOS women with MetS than women without MetS. Also HDL and luteinizing hormone (LH) levels in women with MetS were significantly lower than women without MetS.

Conclusion

Prevalence of MetS in PCOS women was 28.8%, indicating that this value is higher than other studies conducted on PCOS women in Iran and other studies conducted on general population in Iran. PCOS women are considered as a high-risk population for MetS. The special strategies are required to prevent MetS and its associated complications in PCOS women.